FELIX BAKER Insider Trading
Get free email notifications about insider trading for FELIX BAKER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FELIX BAKER. FELIX BAKER is a Director in ALEXION PHARMACEUTICALS INC ($ALXN) and a in SYNAGEVA BIOPHARMA CORP ($GEVA) and a Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and a Director in SEATTLE GENETICS INC /WA ($SGEN) and a Director in GENOMIC HEALTH INC ($GHDX).
Companies in which FELIX BAKER is an Insider
ALEXION PHARMACEUTICALS, INC.
Trading Symbol: ALXNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of FELIX BAKER: Director
Holdings: 6,104,562 shares
Current Value: $779,674,659
Latest Transaction: May 13 2016
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GENOMIC HEALTH INC
Trading Symbol: GHDXIndustry: SERVICES-MEDICAL LABORATORIES [8071]
Position of FELIX BAKER: Director
Holdings: 214,308 shares
Current Value: $5,891,327
Latest Transaction: Jan 04 2017
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seagen Inc.
Trading Symbol: SGENIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of FELIX BAKER: Director
Holdings: 4,842,742 shares
Current Value: $294,390,286
Latest Transaction: Nov 09 2016
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SYNAGEVA BIOPHARMA CORP
Trading Symbol: GEVAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of FELIX BAKER:
Holdings: 0 shares
Latest Transaction: Jun 23 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of FELIX BAKER
Sentiment: All, ALXN, GHDX, SGEN, GEVA
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 29.39 | 680 | 19,985 | 319,993 | 319.3 K to 320 K (+0.21 %) |
Jan 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 29.39 | 680 | 19,985 | 11,350,328 | 11.3 M to 11.4 M (+0.01 %) |
Jan 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 29.39 | 680 | 19,985 | 1,759,659 | 1.8 M to 1.8 M (+0.04 %) |
Jan 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 29.39 | 680 | 19,985 | 33,385 | 32.7 K to 33.4 K (+2.08 %) |
Jan 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 29.39 | 680 | 19,985 | 194,044 | 193.4 K to 194 K (+0.35 %) |
Jan 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 29.39 | 680 | 19,985 | 214,308 | 213.6 K to 214.3 K (+0.32 %) |
Nov 09 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 59.46 | 294,178 | 17,493,177 | 40,885,092 | 40.6 M to 40.9 M (+0.72 %) |